CatalystEarnings

$SRPT — SAREPTA THERAPEUTICS INC

SRPT

$18.99

+2.43%

LLY

$1417.99

+0.61%

JNJ

$276.32

+3.81%

What changed

FQ2 FY2026 (ends Jun) | reported Aug 05: - Revenue: $401M - Adj EPS: $0.64 vs $0.49 🟢 - Op margin: GAAP 3.3% | non-GAAP 54.4% (📉 -15.6pp YoY) Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $1.20B-$1.40B Also in play: $LLY $JNJ $ABBV $UNH $MRK

Why it matters

FQ2 FY2026 (ends Jun) | reported Aug 05:

Sources

pipeline